Related Experiment Video
Updated: Aug 25, 2025

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
Systematic review on efficacy of preventive measures for surgical site infection by multiple-drug resistant
Juliana Arruda de Matos1, Amanda da Silva Gomes2, Carla Ormundo G Ximenes Lima2
1Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad, Rio de Janeiro, RJ, Brazil; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa em Imunização e Vigilância em Saúde, Rio de Janeiro, RJ, Brazil.
Background:
There are no specific recommendations for prevention of surgical site infection (SSI) caused by multidrug resistant Gram-negative bacilli (MDR-GNB). Our objective was to systematically review the literature evaluating the efficacy and safety of measures specifically designed to prevent MDR-GNB SSI.
Methods:
We searched MEDLINE, EMBASE, CINAHL and LILACS databases up to February 18, 2020. Randomized trials and observational cohort studies evaluating the efficacy of preventive measures against MDR-GNB SSI in adult surgical patients were eligible. We evaluated methodological quality of studies and general quality of evidence using Newcastle-Ottawa scale, Cochrane ROBINS-I and GRADE method. Random-effects meta-analyses were performed using Review Manager V.5.3 software.
Results:
A total of 10,663 titles by searching databases were identified. Two retrospective observational studies, comparing surgical antibiotic prophylaxis (SAP) with or without aminoglycoside in renal transplantation recipients, and one non-randomized prospective study, evaluating ertapenem vs. cephalosporin plus metronidazole for SAP in extended spectrum beta-lactamase producing Enterobacteriales carriers undergoing colon surgery, were included. Risk of bias was high in all studies. Meta-analysis was performed for the renal transplantation studies, with 854 patients included. Combined relative risk (RR) for MDR GNB SSI was 0.57 (95%CI: 0.25-1.34), favoring SAP with aminoglycoside (GRADE: moderate).
Conclusions:
There are no sufficient data supporting specific measures against MDR-GNB SSI. Prospective, randomized studies are necessary to assess the efficacy and safety of SAP with aminoglycoside for MDR-GNB SSI prevention among renal transplantation recipients and other populations. PROSPERO 2018 CRD42018100845.
Insights
Current guidelines lack specific strategies to prevent multidrug-resistant Gram-negative bacilli (MDR-GNB) surgical site infections (SSIs). Evidence suggests surgical antibiotic prophylaxis with aminoglycoside may reduce MDR-GNB SSIs in renal transplant recipients, but more research is needed.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Antimicrobial Resistance
Background:
- Surgical site infections (SSIs) caused by multidrug-resistant Gram-negative bacilli (MDR-GNB) lack specific preventive recommendations.
- This systematic review evaluates measures to prevent MDR-GNB SSIs.
Approach:
- Searched MEDLINE, EMBASE, CINAHL, and LILACS databases up to February 18, 2020.
- Included randomized trials and observational cohort studies on preventive measures for MDR-GNB SSIs in adult surgical patients.
- Evaluated study quality using Newcastle-Ottawa, ROBINS-I, and GRADE methods; performed random-effects meta-analyses.
Key Points:
- Identified 10,663 titles; included 3 studies (2 retrospective, 1 prospective).
- Meta-analysis of 2 renal transplantation studies (854 patients) showed a relative risk of 0.57 (95%CI: 0.25-1.34) for MDR-GNB SSI with surgical antibiotic prophylaxis (SAP) including aminoglycoside (GRADE: moderate).
- One study evaluated ertapenem vs. cephalosporin plus metronidazole for SAP in extended-spectrum beta-lactamase producing Enterobacteriales carriers undergoing colon surgery.
Conclusions:
- Insufficient data currently support specific measures against MDR-GNB SSIs.
- Prospective, randomized studies are essential to confirm the efficacy and safety of SAP with aminoglycoside for MDR-GNB SSI prevention in renal transplant recipients and other patient groups.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness
Hand hygiene
Hand washing...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Acute Pyelonephritis II: Diagnostic Studies and Management

